362 related articles for article (PubMed ID: 19396318)
1. [Effect of using icodextrin as a starting therapy for peritoneal permeability].
Fernández-Reyes MJ; Bajo MA; del Peso G; Olea T; Sánchez-Villanueva RL; González E; Heras M; Sánchez R; Selgas R
Nefrologia; 2009; 29(2):130-5. PubMed ID: 19396318
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor.
del Peso G; Fernández-Reyes MJ; Hevia C; Bajo MA; Castro MJ; Cirugeda A; Sánchez-Tomero JA; Selgas R
Nephrol Dial Transplant; 2005 Jun; 20(6):1201-6. PubMed ID: 15827050
[TBL] [Abstract][Full Text] [Related]
3. [Icodextrin as first treatment: reasons to be optimistic].
Rivera M
Nefrologia; 2009; 29(2):99-102. PubMed ID: 19396313
[No Abstract] [Full Text] [Related]
4. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal transport in peritoneal dialysis patients is not affected by transitorily successful renal transplantation.
Fernández EJ; del Peso G; Bajo A; Jiménez C; de Gracia R; Ros S; Selgas R
Adv Perit Dial; 2006; 22():33-6. PubMed ID: 16983935
[TBL] [Abstract][Full Text] [Related]
6. [Clinical experience with icodextrin. Multicenter study].
Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Biocompatibility of Neutral Icodextrin Peritoneal Dialysis Fluid.
Shimada S; Mori T; Koizumi K; Sato S; Oba-Yabana I; Ohsaki Y; Sato E; Naganuma E; Kurasawa N; Tsuchikawa M; Ito S
Adv Perit Dial; 2016; 32():46-50. PubMed ID: 28988589
[TBL] [Abstract][Full Text] [Related]
8. Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD.
Smit W; van den Berg N; Schouten N; Aikens E; Struijk DG; Krediet RT
Kidney Int; 2004 Jan; 65(1):298-303. PubMed ID: 14675063
[TBL] [Abstract][Full Text] [Related]
9. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
[TBL] [Abstract][Full Text] [Related]
10. Icodextrin and intraperitoneal inflammation.
Moriishi M; Kawanishi H
Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
[TBL] [Abstract][Full Text] [Related]
11. Ultrafiltration and small solute transport at initiation of PD: questioning the paradigm of peritoneal function.
Selgas R; Bajo MA; Cirugeda A; del Peso G; Valdés J; Castro MJ; Sánchez S; Fernández-Reyes MJ; Hevia C; Gil F; Aguilera A; Ortiz J; Alegre L; Alvarez V; Sánchez-Tomero JA
Perit Dial Int; 2005; 25(1):68-76. PubMed ID: 15770928
[TBL] [Abstract][Full Text] [Related]
12. The influence of initial peritoneal transport characteristics, inflammation, and high glucose exposure on prognosis for peritoneal membrane function.
Fernández-Reyes MJ; Bajo MA; Del Peso G; Ossorio M; Díaz R; Carretero B; Selgas R
Perit Dial Int; 2012; 32(6):636-44. PubMed ID: 22473036
[TBL] [Abstract][Full Text] [Related]
13. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients.
Chung SH; Heimbürger O; Stenvinkel P; Wang T; Lindholm B
Perit Dial Int; 2003; 23(2):174-83. PubMed ID: 12713086
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal function and adequacy calculations: current programs versus PD Adequest 2.0.
Teixidó-Planas J
Perit Dial Int; 2002; 22(3):386-93. PubMed ID: 12227398
[TBL] [Abstract][Full Text] [Related]
15. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
[TBL] [Abstract][Full Text] [Related]
16. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
Canbakan M; Sahin GM
Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
[TBL] [Abstract][Full Text] [Related]
17. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.
van Esch S; Zweers MM; Jansen MA; de Waart DR; van Manen JG; Krediet RT
Perit Dial Int; 2004; 24(6):554-61. PubMed ID: 15559485
[TBL] [Abstract][Full Text] [Related]
18. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
[TBL] [Abstract][Full Text] [Related]
20. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
Grzegorzewska AE; Leander M; Mariak I
Adv Perit Dial; 2002; 18():33-9. PubMed ID: 12402583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
